Table 3.
Glutathione (GSH) and 8-Hydroxy-2-Deoxyguanosine (8-OH2dG) Levels in Retina After Repeated VEH, NCX 470, LUM, or BIM in ET-1-Treated Eyes
| Group ID | Dose (% w/w) | GSH (µmol/mg Protein) | 8-OH2dG (pg/µg DNA) |
|---|---|---|---|
| Naïve | – | 1.30 ± 0.04 (n = 4) | 18.9 ± 0.7 (n = 3) |
| VEH | – | 0.37 ± 0.04a (n = 6) | 57.5 ± 6.3a (n = 6) |
| NCX 470 | 0.1 | 1.31 ± 0.25b (n = 6) | 34.1 ± 5.0b,c (n = 6) |
| LUM | 0.01 | 1.09 ± 0.07b (n = 4) | 51.8 ± 3.5 (n = 5) |
| BIM | 0.072 | 1.39 ± 0.23b (n = 4) | 41.5 ± 1.9 (n = 6) |
GSH and 8-OH2dG levels in naïve eyes or at week 6 in eyes treated with VEH, NCX 470, LUM, and BIM. Data are mean ± SEM, multiple t-test with Welch correction.
p < 0.05 versus naïve.
p < 0.05 versus vehicle.
c p < 0.05 versus LUM or BIM.